BotanyBoy
Fuck Your Safe Space
- Joined
- Jun 28, 2012
- Posts
- 52,256
You appear to be a compulsive liar.
So GFY, libertard.
_________________
Look at all that butt hurt

Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
You appear to be a compulsive liar.
So GFY, libertard.
_________________
I just can't imagine what it must be like to go through life like you must. And I don't want to.
I don't give a fuck about you other than you for you to stop stalking me.
OK cunt?
Just fuck off, yeah?
U.S. lawmakers on Wednesday blasted steep price increases for Mylan’s EpiPen emergency allergy treatment as they grilled the company’s Chief Executive Heather Bresch at a congressional hearing. The House Committee on Oversight and Government Reform called Bresch to testify after the company raised the list price for a pair of EpiPens to $600 compared with $100 in 2007, when it acquired the product.
Congressman Elijah Cummings, ranking Democrat on the committee, said Mylan “jacked up” the price of the life-saving product “to get filthy rich at the expense of our constituents.”
“After Mylan takes our punches they’ll fly back to their mansions in their private jets and laugh all the way to the bank,” Cummings said.
Committee Chairman Jason Chaffetz of Utah noted that Mylan said it would soon sell a generic version of EpiPen for about $300. “Suddenly feeling the heat Mylan has offered a generic version and cut the price in half, so that does beg the question what was happening with that other $300?”
Holding up an EpiPen, he said: “the actual juice that’s in here that you need costs about a dollar.”
West Virginia Attorney General Patrick Morrisey on Wednesday blasted a pending $465 million settlement between Mylan NV and the U.S. Justice Department over the misclassification of the EpiPen, saying it was “woefully deficient.”
In a Nov. 2 letter to Attorney General Loretta Lynch, Morrisey said the amount likely fell short of how much the company owed Medicaid, and that Mylan should “not be allowed to receive a windfall after flagrantly defrauding the Medicaid Drug Rebate Program.”
Spokeswomen for the U.S. Justice Department and Mylan did not immediately respond to requests for comment.
Morrisey’s letter came just a few weeks after Mylan announced a $465 million settlement with the Justice Department over charges it had underpaid U.S. government healthcare programs by misclassifying the EpiPen.
For years, the company had classified the allergy treatment as a generic drug instead of a branded one, resulting in smaller rebates to state and federal Medicaid programs.
The Medicaid rebate for a generic is 13 percent compared with a minimum 23.1 percent for a branded drug.
Obama Appointee a shill for Big Pharma?